The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs
Open accessAbstract
Safe induction of autoantigen-specific long-term tolerance is the "holy grail" for the treatment of autoimmune diseases. In animal models of type 1 diabetes, oral or i.n. immunization with islet antigens induces Tregs that are capable of bystander suppression. However, such interventions are only effective early in the prediabetic phase. Here, we demonstrate that a novel combination treatment with anti-CD3epsilon-specific antibody and i.n. proinsulin peptide can reverse recent-onset diabetes in 2 murine diabetes models with much higher efficacy than with monotherapy with anti-CD3 or antigen alone. In vivo, expansion of CD25(+)Foxp3(+) and insulin-specific Tregs producing IL-10, TGF-beta, and IL-4 was strongly enhanced. These cells could transfer dominant tolerance to immunocompetent recent-onset diabetic recipients and suppressed heterologous autoaggressive CD8 responses. Thus, combining a systemic immune modulator with antigen-specific Treg induction is more efficacious in reverting diabetes. Since Tregs act site-specifically, this strategy should also be expected to reduce the potential for systemic side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., & Sakaguchi, S. (2002) · Nature Immunology · doi:10.1038/ni759 · Cited by 1,729
CD4+CD25+ Immunoregulatory T Cells
McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M., & Byrne, M. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00280-7 · Cited by 1,395
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
THE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
Nakayama, M., Abiru, N., Moriyama, H., Babaya, N., Liu, E., Miao, D., Yu, L., Wegmann, D. R., Hutton, J. C., Elliott, J. F., et al. (2005) · Nature · doi:10.1038/nature03523 · Cited by 758
Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P., & Steinman, R. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040180 · Cited by 738
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud, L., Thervet, E., Primo, J., & Bach, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.123 · Cited by 664
Herold, K. C., Gitelman, S. E., Masharani, U., Hagopian, W., Bisikirska, B., Donaldson, D., Rother, K., Diamond, B., Harlan, D. M., & Bluestone, J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1763 · Cited by 634
Belghith, M., Bluestone, J. A., Barriot, S., Mégret, J., Bach, J.-F., & Chatenoud, L. (2003) · Nature Medicine · doi:10.1038/nm924 · Cited by 586
CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice
Chatenoud, L., Primo, J., & Bach, J. F. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2947 · Cited by 417
Kent, S. C., Chen, Y., Bregoli, L., Clemmings, S. M., Kenyon, N. S., Ricordi, C., Hering, B. J., & Hafler, D. A. (2005) · Nature · doi:10.1038/nature03625 · Cited by 409
Lieberman, S. M., Evans, A. M., Han, B., Takaki, T., Vinnitskaya, Y., Caldwell, J. A., Serreze, D. V., Shabanowitz, J., Hunt, D. F., Nathenson, S. G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932778100 · Cited by 388
Bisikirska, B., Colgan, J., Luban, J., Bluestone, J. A., & Herold, K. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23961 · Cited by 339
Peptide-based therapeutic vaccines for allergic and autoimmune diseases
Larché, M., & Wraith, D. C. (2005) · Nature Medicine · doi:10.1038/nm1226 · Cited by 326
CD3-specific antibody-induced active tolerance: from bench to bedside
Chatenoud, L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1000 · Cited by 309
How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model
von Herrath, M. G., Dockter, J., & Oldstone, M. B. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90101-5 · Cited by 304
Suppressor T cells – they’re back and critical for regulation of autoimmunity!
Chatenoud, L., Salomon, B., & Bluestone, J. A. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820112.x · Cited by 273
Lundgren, A., Strömberg, E., Sjöling, A., Lindholm, C., Enarsson, K., Edebo, A., Johnsson, E., Suri-Payer, E., Larsson, P., Rudin, A., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.523-531.2005 · Cited by 268
Homann, D., Holz, A., Bot, A., Coon, B., Wolfe, T., Petersen, J., Dyrberg, T. P., Grusby, M. J., & von Herrath, M. G. (1999) · Immunity · doi:10.1016/s1074-7613(00)80121-1 · Cited by 181
Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala)
Herold, K. C., Burton, J. B., Francois, F., Poumian-Ruiz, E., Glandt, M., & Bluestone, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16090 · Cited by 177
von Herrath, M. G., Dyrberg, T., & Oldstone, M. B. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118919 · Cited by 152
Kohm, A. P., Williams, J. S., Bickford, A. L., McMahon, J. S., Chatenoud, L., Bach, J., Bluestone, J. A., & Miller, S. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4525 · Cited by 145
Alleva, D. G., Gaur, A., Jin, L., Wegmann, D. R., Gottlieb, P. A., Pahuja, A., Johnson, E. B., Motheral, T., Putnam, A. L., Crowe, P. D., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2126 · Cited by 126
A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes
Christen, U., Edelmann, K. H., McGavern, D. B., Wolfe, T., Coon, B., Teague, M. K., Miller, S. D., Oldstone, M. B. A., & von Herrath, M. G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22557 · Cited by 121
DNA immunization to prevent autoimmune diabetes
Coon, B., An, L., Whitton, J. L., & von Herrath, M. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7209 · Cited by 118
Ploix, C. C., Lo, D. D., & Carson, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6724 · Cited by 97
Martinez, N. R., Augstein, P., Moustakas, A. K., Papadopoulos, G. K., Gregori, S., Adorini, L., Jackson, D. C., & Harrison, L. C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17166 · Cited by 97
Control freaks: immune regulatory cells
Nagler‐Anderson, C., Bhan, A. K., Podolsky, D. K., & Terhorst, C. (2004) · Nature Immunology · doi:10.1038/ni0204-119 · Cited by 82
Insulin in Oral Immune “Tolerance”: A One-Amino Acid Change in the B Chain Makes the Difference
Homann, D., Dyrberg, T., Petersen, J. S., Oldstone, M. B. A., & von Herrath, M. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1833 · Cited by 79
Type 1A diabetes mellitus-associated autoimmunity
Liu, E., & Eisenbarth, G. S. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00017-2 · Cited by 71
The Role of CD28 and CTLA4 in the Function and Homeostasis of CD4 + CD25 + Regulatory T Cells
Boden, E. K., Tang, Q., Bour‐Jordan, H., & Bluestone, J. A. (2003) · Novartis Foundation symposium · doi:10.1002/0470871628.ch5 · Cited by 57
Mukherjee, R., Wagar, D., Stephens, T. A., Lee‐Chan, E., & Singh, B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5306 · Cited by 51
Intranasal Administration of Insulin Peptide B: 9–23 Protects NOD Mice from Diabetes
Daniel, D., & Wegmann, D. R. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb21146.x · Cited by 43
CD3 Antibody Treatment Stimulates the Functional Capability of Regulatory T Cells
Chatenoud, L. (2003) · Novartis Foundation symposium · doi:10.1002/0470871628.ch21 · Cited by 36
Mahon, J. L., DUPRE, J., & STILLER, C. R. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17171.x · Cited by 20
Immune intervention with anti-CD3 in diabetes
Harlan, D. M., & von Herrath, M. (2005) · Nature Medicine · doi:10.1038/nm0705-716 · Cited by 14
Cited by
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Recovery from diabetes in mice by β cell regeneration
Nir, T., Melton, D. A., & Dor, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32959 · Cited by 595
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K. M., Pennington, M. W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605136103 · Cited by 538
Weiner, H. L., da Cunha, A. P., Quintana, F., & Wu, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01017.x · Cited by 535
Metadata
- Authors
- Bresson, D.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-05-01
- Volume
- 116
- Issue
- 5
- Pages
- 1371-1381
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1963770029
- Cited by
- 293
- References
- 38
- FWCI
- 18.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.